Subcutaneous injection of triamcinolone acetonide in the treatment of chronic vulvar pruritus.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8372864.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We studied the efficacy of subcutaneous corticosteroid injection as therapy for chronic vulvar pruritus. Adult women with symptoms of vulvar pruritus > 6 months were studied. After appropriate biopsies and cultures were performed, patients were included in the study group if they experienced limited relief with topical triamcinolone cream. Triamcinolone acetonide (15 to 20 mg) was injected subcutaneously and massaged into the affected vulvar tissue. Seventy-eight percent of patients (35/45) experienced relief of vulvar pruritus for > 1 month (mean duration 5.8 months). We found that subcutaneous injection triamcinolone acetonide provided relief of symptoms of chronic vulvar pruritus.
Medical subject headings
- Pruritus Vulvae
- Triamcinolone Acetonide